Research and development

The Trump administration's proposed federal budget eliminates ongoing funding for ShakeAlert, an earthquake early warning system co-developed at Berkeley.

Potentially revolutionizing the development of drugs for psychiatric disorders, including depression and schizophrenia, assistant chemical engineering professor Markita Landry is developing technology that will enable X-rays of brain tissue in live mice.

The common finger-stick method of checking blood sugar levels may not be necessary for a large number of people with diabetes.

Basilea awarded USD 54.8 million of additional funding by BARDA to support phase 3 development of ceftobiprole

Some 37 countries, 28 of which are in Africa, require external assistance for food, according to FAO's new Crop Prospects and Food Situation report.

Astellas today announced data from an exploratory analysis of the Phase I/II CHRYSALIS study, which demonstrated that FLT3 mutation-positive relapsed/refractory (R/R) AML patients with molecular response had improved OS compared with those without a molecular response

More people are connecting to the grid as living standards improve around the world.

Novartis drug Tasigna receives EU approval for inclusion of Treatment-free Remission (TFR) data in product label

Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the signing of an agreement granting the exclusive right to market NATESTO^® in Saudi Arabia, the United Arab Emirates and Egypt to Therios Healthcare

IBM today announced that Baheal Pharmaceutical Group is extending the reach of Watson for Oncology to clinicians across China through a new multi-year strategic alliance. 

Novartis presents updated data that reinforce the efficacy and safety of Kisqali® (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer

Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced its financial results for the first quarter ended March 31, 2017

On SPIEF-2017 CEO of Carlsberg Group will discuss Russia’s participation in the green politics

JSE Limited listed Aspen Pharmacare (APN), a leading pharmaceutical company in the southern hemisphere, has announced that a memorandum of understanding (“MOU”) has been concluded between Aspen’s Russian business and the Vladivostok Far Eastern Federal University